Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ADRX-0405 |
| Trade Name | |
| Synonyms | ADRX 0405|ADRX0405 |
| Drug Descriptions |
ADRX-0405 is an antibody-drug conjugate (ADC) comprising an antibody targeting STEAP1 linked to a topoisomerase I inhibitor, which potentially induces cytotoxicity in STEAP1-expressing tumor cells and inhibits tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 1159). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C215119 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ADRX-0405 | ADRX-0405 | 0 | 1 |